Working... Menu
Trial record 3 of 30 for:    Recruiting Studies | Huntington Disease

Nilotinib in Huntington's Disease (Tasigna HD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03764215
Recruitment Status : Recruiting
First Posted : December 5, 2018
Last Update Posted : December 5, 2018
Information provided by (Responsible Party):
Karen E. Anderson, MD, Georgetown University